The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing antibody therapies for cancer.

Total Raised

$59 M

Rounds

1

Links

Verticals

Biotechnology
FinTech
Life Science
Medical
Oncology

Investment History

  1. Equity

    Nov 2025

    $59M

Team

Douglas E. Onsi

Chief Financial Officer

Mark Mahony

Chief Manufacturing Officer

Chris Mirabelli

Chairman of the Board

Will McEvoy

Chief Investment Officer